Kenvue says Tylenol is safe, but stock hits record low ahead of Trump speech
Up next
Author


Kenvue’s stock was heading for a record low as investors express concerns over what President Trump will say regarding the use of acetaminophen — the active ingredient in Tylenol — and the autism epidemic.

You May Also Like
Oil prices consolidate as investors weigh China demand

Oil prices consolidate as investors weigh China demand

Oil futures hovered near unchanged early Tuesday, consolidating after a pullback the…
Lowe’s tops Home Depot with an $8.8 billion buyout deal and an earnings beat

Lowe’s tops Home Depot with an $8.8 billion buyout deal and an earnings beat

Lowe’s stock gains after it beat earnings expectations a day after Home…

Network North is not fully costed and beset by uncertainty, warn experts

Rishi Sunak’s £36bn plan to replace the northern leg of the HS2…
Investors are jittery about earnings — and that’s opening up big opportunities, say Goldman strategists

Investors are jittery about earnings — and that’s opening up big opportunities, say Goldman strategists

Looking at the demand for put over call options, fear remains at…